These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2224723)

  • 1. Report on UK cancer survival rates raises questions about alternative medicine.
    Richmond C
    CMAJ; 1990 Nov; 143(9):922-3. PubMed ID: 2224723
    [No Abstract]   [Full Text] [Related]  

  • 2. UK death rates from breast cancer fall by a third.
    Brown P
    BMJ; 2000 Oct; 321(7265):849. PubMed ID: 11021849
    [No Abstract]   [Full Text] [Related]  

  • 3. Five year survival from breast cancer is lower in deprived areas, says UK report.
    Mayor S
    BMJ; 2011 Jun; 342():d3661. PubMed ID: 21669952
    [No Abstract]   [Full Text] [Related]  

  • 4. [Are there alternative therapeutic methods for breast carcinoma? Status and perspectives for treatment of metastatic breast carcinoma].
    Unger C; Marmé D
    Gynakologe; 1994 Dec; 27(6):387-90. PubMed ID: 7531169
    [No Abstract]   [Full Text] [Related]  

  • 5. Frequency of use of complementary and alternative medicine in women with breast cancer.
    Lengacher CA; Bennett MP; Kip KE; Keller R; LaVance MS; Smith LS; Cox CE
    Oncol Nurs Forum; 2002; 29(10):1445-52. PubMed ID: 12432415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bristol study should be retracted.
    Bull Med Ethics; 1991 Dec; 74():3-6. PubMed ID: 16144142
    [No Abstract]   [Full Text] [Related]  

  • 7. Group mediation of complementary and alternative medicine in cancer care in the UK and Pakistan.
    Tovey P
    Eur J Cancer Care (Engl); 2003 Dec; 12(4):374-5. PubMed ID: 14982319
    [No Abstract]   [Full Text] [Related]  

  • 8. UK has highest reduction in deaths from lung and breast cancer.
    McKenna C
    BMJ; 2002 Jul; 325(7355):63A. PubMed ID: 12114230
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival from breast cancer in England and Wales up to 2001.
    Leary A; Smith IE
    Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S56-8. PubMed ID: 18813261
    [No Abstract]   [Full Text] [Related]  

  • 10. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.
    Peto R; Boreham J; Clarke M; Davies C; Beral V
    Lancet; 2000 May; 355(9217):1822. PubMed ID: 10832853
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast cancer survival in England, Norway and Sweden: a population-based comparison.
    Møller H; Sandin F; Bray F; Klint A; Linklater KM; Purushotham A; Robinson D; Holmberg L
    Int J Cancer; 2010 Dec; 127(11):2630-8. PubMed ID: 20162669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in breast cancer incidence, survival, and mortality.
    Pujol H
    Lancet; 2000 Aug; 356(9229):591-2; author reply 593. PubMed ID: 10950253
    [No Abstract]   [Full Text] [Related]  

  • 13. Complementary and alternative medicine use among women with breast cancer.
    DiGianni LM; Garber JE; Winer EP
    J Clin Oncol; 2002 Sep; 20(18 Suppl):34S-8S. PubMed ID: 12235222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer. Mortality and morbidity.
    Br J Theatre Nurs; 1997 Apr; 7(1):32-3. PubMed ID: 9146144
    [No Abstract]   [Full Text] [Related]  

  • 15. UK deaths from breast cancer fall to lowest figure for 40 years.
    Mayor S
    BMJ; 2009 Apr; 338():b1710. PubMed ID: 19401325
    [No Abstract]   [Full Text] [Related]  

  • 16. An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast.
    du Toit RS; Locker AP; Ellis IO; Elston CW; Nicholson RI; Robertson JF; Blamey RW
    Eur J Surg Oncol; 1991 Jun; 17(3):251-7. PubMed ID: 1646127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bristol Cancer Help Centre.
    Lancet; 1990 Sep; 336(8717):743-4. PubMed ID: 1975908
    [No Abstract]   [Full Text] [Related]  

  • 18. Trends in breast cancer incidence, survival, and mortality.
    Goodare H
    Lancet; 2000 Aug; 356(9229):591; author reply 593. PubMed ID: 10950252
    [No Abstract]   [Full Text] [Related]  

  • 19. Trends in breast cancer incidence, survival, and mortality.
    Coleman MP
    Lancet; 2000 Aug; 356(9229):590-1; author reply 593. PubMed ID: 10950250
    [No Abstract]   [Full Text] [Related]  

  • 20. Shortened survival and more metastasis recurrences among overweight breast cancer patients.
    Majed B; Senouci K; Asselain B
    Breast J; 2009; 15(5):557-9. PubMed ID: 19671109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.